|
Risk of second primary cancer after first primary male breast cancer diagnosis by race |
||||||||||
| Race |
||||||||||
|
|
||||||||||
| Non-Hispanic white |
Other |
|||||||||
|
|
||||||||||
| Cancer Site |
N |
PERYR |
OBS |
EXP |
SIR (95 percent CI) |
N |
PERYR |
OBS |
EXP |
SIR (95 percent CI) |
|
|
||||||||||
| All, breast included |
1,454 |
6,523.25 |
182 |
153.02 |
1.19 (1.02–1.38) |
472 |
1,936.84 |
39 |
37.40 |
1.04 (0.74–1.43) |
| All, breast excluded |
1,454 |
6,572.88 |
168 |
153.92 |
1.09 (0.93–1.27) |
472 |
1,956.75 |
33 |
37.71 |
0.88 (0.60–1.23) |
| Prostate |
1,454 |
6,801.52 |
55 |
57.34 |
0.96 (0.72–1.25) |
472 |
2,002.21 |
14 |
14.96 |
0.94 (0.51–1.57) |
| Second breast |
1,437 |
6,908.47 |
14 |
0.31 |
44.73 (24.45–75.04) |
469 |
2,039.42 |
6 |
0.07 |
84.83 (31.13–184.63) |
| Colorectal |
1,454 |
6,976.41 |
22 |
18.32 |
1.20 (0.75–1.82) |
472 |
2,049.09 |
4 |
4.32 |
0.93 (0.25–2.37) |
| Lung and bronchus |
1,454 |
6,999.32 |
19 |
26.40 |
0.72 (0.43–1.12) |
472 |
2,066.43 |
4 |
6.36 |
0.63 (0.17–1.61) |
| Bladder |
1,454 |
6,963.65 |
19 |
11.93 |
1.59 (0.96–2.49) |
472 |
2,067.37 |
1 |
1.53 |
0.65 (0.02–3.65) |
| Melanomaa |
1,454 |
6,971.11 |
14 |
4.69 |
2.98 (1.63–5.00) |
- |
- |
- |
- |
- |
| Stomach |
1,454 |
7,013.32 |
8 |
3.16 |
2.53 (1.09–4.99) |
472 |
2,061.12 |
2 |
1.58 |
1.27 (0.15–4.57) |
|
Bold numbers indicate that the 95 percent confidence interval (CI) does not include 1.00. aNon-Hispanic whites only. EXP, expected; N, number of subjects; OBS, observed; PERYR, person years at risk; SIR, standardized incidence ratios. | ||||||||||
Satram-Hoang et al. Breast Cancer Research 2007 9:R10 doi:10.1186/bcr1643 |
||||||||||